Lucinda Jane England
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lucinda Jane England has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
Shin Y. Kim
4 shared publicationsVan T. Tong
Division of Reproductive Health Centers for Disease Control and Prevention Atlanta Georgia
3 shared publicationsWilliam M. Callaghan
Centers for Disease Control and Prevention, Atlanta, GA
3 shared publicationsCarrie K. Shapiro‐Mendoza
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA
2 shared publicationsClaire A. Lewis
Yukon Kuskokwim Health Corporation, Bethel, Alaska, USA
2 shared publicationsCong Qian
The Allied Technology Group Rockville, MD
2 shared publications
Latest Publications
- 8 May 2024
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 38 (4) , 327-329
Reducing the burden from tobacco‐related complications of pregnancy in the United States
- 8 May 2024
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 38 (4) , 327-329
Reducing the burden from tobacco‐related complications of pregnancy in the United States
- Open Access
Characterization of Cleaning and Disinfection Product Use, Glove Use, and Skin Disorders by Healthcare Occupations in a Midwestern Healthcare Facility
Healthcare facility staff use a wide variety of cleaning and disinfecting products during their daily operations, many of which are associated with respiratory or skin irritation or sensitization with repeated exposure. The objective of this study was to characterize the prevalence of cleaning and disinfection product use, glove use during cleaning and disinfection, and skin/allergy symptoms by occupation and identify the factors influencing glove use among the healthcare facility staff. A questionnaire was administered to the current employees at a midwestern Veterans Affairs healthcare facility that elicited information on cleaning and disinfection product use, glove use during cleaning and disinfection, skin/allergy symptoms, and other demographic characteristics, which were summarized by occupation. The central supply/environmental service workers (2% of the total survey population), nurses (26%,), nurse assistants (3%), and laboratory technicians (5%) had the highest prevalence of using cleaning or disinfecting products, specifically quaternary ammonium compounds, bleach, and alcohol. Glove use while using products was common in both patient care and non-patient care occupations. The factors associated with glove use included using bleach or quaternary ammonium compounds and using cleaning products 2–3 or 4–5 days per week. A high frequency of glove use (≥75%) was reported by workers in most occupations when using quaternary ammonium compounds or bleach. The use of alcohol, bleach, and quaternary ammonium compounds was associated with skin disorders (p < 0.05). These research findings indicate that although the workers from most occupations report a high frequency of glove use when using cleaning and disinfection products, there is room for improvement, especially among administrative, maintenance, and nursing workers. These groups may represent populations which could benefit from the implementation of workplace interventions and further training regarding the use of personal protective equipment and the potential health hazards of exposure to cleaning and disinfecting chemicals.
Open AccessCharacterization of Cleaning and Disinfection Product Use, Glove Use, and Skin Disorders by Healthcare Occupations in a Midwestern Healthcare Facility
Healthcare facility staff use a wide variety of cleaning and disinfecting products during their daily operations, many of which are associated with respiratory or skin irritation or sensitization with repeated exposure. The objective of this study was to characterize the prevalence of cleaning and disinfection product use, glove use during cleaning and disinfection, and skin/allergy symptoms by occupation and identify the factors influencing glove use among the healthcare facility staff. A questionnaire was administered to the current employees at a midwestern Veterans Affairs healthcare facility that elicited information on cleaning and disinfection product use, glove use during cleaning and disinfection, skin/allergy symptoms, and other demographic characteristics, which were summarized by occupation. The central supply/environmental service workers (2% of the total survey population), nurses (26%,), nurse assistants (3%), and laboratory technicians (5%) had the highest prevalence of using cleaning or disinfecting products, specifically quaternary ammonium compounds, bleach, and alcohol. Glove use while using products was common in both patient care and non-patient care occupations. The factors associated with glove use included using bleach or quaternary ammonium compounds and using cleaning products 2–3 or 4–5 days per week. A high frequency of glove use (≥75%) was reported by workers in most occupations when using quaternary ammonium compounds or bleach. The use of alcohol, bleach, and quaternary ammonium compounds was associated with skin disorders (p < 0.05). These research findings indicate that although the workers from most occupations report a high frequency of glove use when using cleaning and disinfection products, there is room for improvement, especially among administrative, maintenance, and nursing workers. These groups may represent populations which could benefit from the implementation of workplace interventions and further training regarding the use of personal protective equipment and the potential health hazards of exposure to cleaning and disinfecting chemicals.
- 7 August 2020
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 69 (31) , 1009-1014
Alcohol Use and Co-Use of Other Substances Among Pregnant Females Aged 12–44 Years — United States, 2015–2018
This report describes use of alcohol along with other substances among pregnant females aged 12–44 years.
- 7 August 2020
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 69 (31) , 1009-1014
Alcohol Use and Co-Use of Other Substances Among Pregnant Females Aged 12–44 Years — United States, 2015–2018
This report describes use of alcohol along with other substances among pregnant females aged 12–44 years.
Biochemically confirmed smoking cessation and gestational weight gain
Background: Prenatal smoking cessation has substantial health benefits for mothers and offspring, but concerns about weight gain may be a barrier to quitting. We quantified gestational weight gain associated with biochemically confirmed smoking cessation.Methods: Data originated from a randomized controlled cessation trial: Smoking Cessation in Pregnancy project (1987‐1991). We calculated gestational weight gain using self‐reported prepregnancy weight and measured weight at 30‐34 weeks of gestation. We used linear regression to estimate adjusted mean differences in gain for quitters versus continuing smokers by the last trimester. The effects of quitting earlier (by 2nd trimester) versus later (by 3rd trimester) were calculated. We assessed the percentages who gained weight according to Institute of Medicine (IOM) recommendations within 2 weeks of a full‐term delivery.Results: At 30‐34 weeks, nulliparous and multiparous quitters gained an average of 3.0 pounds (95% CI 0.9‐5.1 pounds) (1.4 kg [0.4‐2.3 kg]) and 6.6 pounds (95% CI 4.3‐8.9 pounds) (3.0 kg [1.9‐4.0 kg]) more, respectively, than continuing smokers. Weight gain in early quitters did not differ significantly from that in late quitters. Quitters were more likely than continuing smokers to gain above current guidelines (60.3% vs 46.3%) and were less likely to gain below guidelines (11.5% vs 21.6%) (P = 0.002).Conclusions: Although quitters had modest additional weight gain by 30‐34 weeks compared to continuing smokers, a high proportion in both groups gained in excess of IOM recommendations. Both quitters and continuing smokers may need support to achieve optimal gestational weight gain.
Biochemically confirmed smoking cessation and gestational weight gain
Background: Prenatal smoking cessation has substantial health benefits for mothers and offspring, but concerns about weight gain may be a barrier to quitting. We quantified gestational weight gain associated with biochemically confirmed smoking cessation.Methods: Data originated from a randomized controlled cessation trial: Smoking Cessation in Pregnancy project (1987‐1991). We calculated gestational weight gain using self‐reported prepregnancy weight and measured weight at 30‐34 weeks of gestation. We used linear regression to estimate adjusted mean differences in gain for quitters versus continuing smokers by the last trimester. The effects of quitting earlier (by 2nd trimester) versus later (by 3rd trimester) were calculated. We assessed the percentages who gained weight according to Institute of Medicine (IOM) recommendations within 2 weeks of a full‐term delivery.Results: At 30‐34 weeks, nulliparous and multiparous quitters gained an average of 3.0 pounds (95% CI 0.9‐5.1 pounds) (1.4 kg [0.4‐2.3 kg]) and 6.6 pounds (95% CI 4.3‐8.9 pounds) (3.0 kg [1.9‐4.0 kg]) more, respectively, than continuing smokers. Weight gain in early quitters did not differ significantly from that in late quitters. Quitters were more likely than continuing smokers to gain above current guidelines (60.3% vs 46.3%) and were less likely to gain below guidelines (11.5% vs 21.6%) (P = 0.002).Conclusions: Although quitters had modest additional weight gain by 30‐34 weeks compared to continuing smokers, a high proportion in both groups gained in excess of IOM recommendations. Both quitters and continuing smokers may need support to achieve optimal gestational weight gain.
- Open Access
Evaluation of a federally funded mass media campaign and smoking cessation in pregnant women: a population-based study in three states
Objectives: In 2012, theCenters for Disease Control and Prevention initiated a national anti-smoking campaign,Tips from Former Smokers(Tips). As a result of the campaign, quit attempts among smokers increased in the general population by 3.7 percentage points. In the current study, we assessed the effects ofTipson smoking cessation in pregnant women.Methods: We used 2009–2013 certificates of live births in three US states: Indiana, Kentucky and Ohio. Smoking cessation by the third trimester of pregnancy was examined among women who smoked in the 3 months prepregnancy. Campaign exposure was defined as overlap between the airing ofTips2012 (March 19–June 10) and the prepregnancy and pregnancy periods. Women who delivered beforeTips2012 were not exposed. Adjusted logistic regression was used to determine whether exposure toTipswas independently associated with smoking cessation.Results: Cessation rates were stable during 2009–2011 but increased at the timeTips2012 aired and remained elevated. Overall, 32.9% of unexposed and 34.7% of exposed smokers quit by the third trimester (pTips2012 was associated with increased cessation (adjusted OR: 1.07, 95% CI 1.05 to 1.10).Conclusions: Exposure to a national anti-smoking campaign for a general audience was associated with smoking cessation in pregnant women.
Open AccessEvaluation of a federally funded mass media campaign and smoking cessation in pregnant women: a population-based study in three states
Objectives: In 2012, theCenters for Disease Control and Prevention initiated a national anti-smoking campaign,Tips from Former Smokers(Tips). As a result of the campaign, quit attempts among smokers increased in the general population by 3.7 percentage points. In the current study, we assessed the effects ofTipson smoking cessation in pregnant women.Methods: We used 2009–2013 certificates of live births in three US states: Indiana, Kentucky and Ohio. Smoking cessation by the third trimester of pregnancy was examined among women who smoked in the 3 months prepregnancy. Campaign exposure was defined as overlap between the airing ofTips2012 (March 19–June 10) and the prepregnancy and pregnancy periods. Women who delivered beforeTips2012 were not exposed. Adjusted logistic regression was used to determine whether exposure toTipswas independently associated with smoking cessation.Results: Cessation rates were stable during 2009–2011 but increased at the timeTips2012 aired and remained elevated. Overall, 32.9% of unexposed and 34.7% of exposed smokers quit by the third trimester (pTips2012 was associated with increased cessation (adjusted OR: 1.07, 95% CI 1.05 to 1.10).Conclusions: Exposure to a national anti-smoking campaign for a general audience was associated with smoking cessation in pregnant women.
- Top Cited PapersOpen Access
- 1 January 2017
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 72, 176-189
Developmental toxicity of nicotine: A transdisciplinary synthesis and implications for emerging tobacco products
- 1 January 2017
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 72, 176-189
Top Cited PapersOpen AccessDevelopmental toxicity of nicotine: A transdisciplinary synthesis and implications for emerging tobacco products
- Open Access
- 1 December 2016
- Published by Elsevier in Preventive Medicine Reports
- Vol. 4, 481-485
Perceptions of emerging tobacco products and nicotine replacement therapy among pregnant women and women planning a pregnancy
- 1 December 2016
- Published by Elsevier in Preventive Medicine Reports
- Vol. 4, 481-485
Open AccessPerceptions of emerging tobacco products and nicotine replacement therapy among pregnant women and women planning a pregnancy
- Open Access
- 1 July 2016
- Published by American Public Health Association in American Journal of Public Health
- Vol. 106 (7) , 1219-1222
New Product Marketing Blurs the Line Between Nicotine Replacement Therapy and Smokeless Tobacco Products
Tobacco companies have begun to acquire pharmaceutical subsidiaries and recently started to market nicotine replacement therapies, such as Zonnic nicotine gum, in convenience stores. Conversely, tobacco companies are producing tobacco products such as tobacco chewing gum and lozenges that resemble pharmaceutical nicotine replacement products, including a nicotine pouch product that resembles snus pouches. This convergence of nicotine and tobacco product marketing has implications for regulation and tobacco cessation.
- 1 July 2016
- Published by American Public Health Association in American Journal of Public Health
- Vol. 106 (7) , 1219-1222
Open AccessNew Product Marketing Blurs the Line Between Nicotine Replacement Therapy and Smokeless Tobacco Products
Tobacco companies have begun to acquire pharmaceutical subsidiaries and recently started to market nicotine replacement therapies, such as Zonnic nicotine gum, in convenience stores. Conversely, tobacco companies are producing tobacco products such as tobacco chewing gum and lozenges that resemble pharmaceutical nicotine replacement products, including a nicotine pouch product that resembles snus pouches. This convergence of nicotine and tobacco product marketing has implications for regulation and tobacco cessation.
- 14 September 2015
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 29 (6) , 562-566
Investigating Implausible Gestational Age and High Birthweight Combinations
Background: Birth certificate data overestimate national preterm births because a high percentage of last menstrual period (LMP) dates have errors. Study goals were to determine: (i) To what extent errors in transfer of birthweight and LMP date from medical records to birth certificates contribute to implausibly high birthweight‐for‐gestational‐age births; (ii) What percentage of implausible births would be resolved if the clinical estimate (CE) from birth certificates were used instead of LMP‐based gestational age, and with what degree of certainty; and (iii) Of those not resolved, what percentage had a medical explanation.Methods: Medical records and birth certificates for all singleton infants with implausibly high birthweight‐for‐gestational‐age based on LMP delivered in the Kaiser Permanente Northwest system in Oregon during 1998–2007 were examined. Percentages of implausible records resolved under various scenarios were calculated.Results: A total of 100 births with implausibly high birthweight‐for‐gestational age combinations were identified. When LMP date and birthweight from medical records were used instead of from birth certificates, 31% of births with implausible combinations were resolved. Substituting the CE on the birth certificate for the LMP date resolved 92%. Of the latter, the clinician's gestational age estimate in the medical record was obtained in early pregnancy in 72%. Five of the eight births with unresolved implausible combinations were to mothers with diabetes; the remaining three had no documented medical explanation.Conclusions: In this study, use of the birth certificate CE rather than the LMP resulted in a clinically reliable reclassification for the majority of implausible birthweight‐for‐gestational age deliveries.
- 14 September 2015
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 29 (6) , 562-566
Investigating Implausible Gestational Age and High Birthweight Combinations
Background: Birth certificate data overestimate national preterm births because a high percentage of last menstrual period (LMP) dates have errors. Study goals were to determine: (i) To what extent errors in transfer of birthweight and LMP date from medical records to birth certificates contribute to implausibly high birthweight‐for‐gestational‐age births; (ii) What percentage of implausible births would be resolved if the clinical estimate (CE) from birth certificates were used instead of LMP‐based gestational age, and with what degree of certainty; and (iii) Of those not resolved, what percentage had a medical explanation.Methods: Medical records and birth certificates for all singleton infants with implausibly high birthweight‐for‐gestational‐age based on LMP delivered in the Kaiser Permanente Northwest system in Oregon during 1998–2007 were examined. Percentages of implausible records resolved under various scenarios were calculated.Results: A total of 100 births with implausibly high birthweight‐for‐gestational age combinations were identified. When LMP date and birthweight from medical records were used instead of from birth certificates, 31% of births with implausible combinations were resolved. Substituting the CE on the birth certificate for the LMP date resolved 92%. Of the latter, the clinician's gestational age estimate in the medical record was obtained in early pregnancy in 72%. Five of the eight births with unresolved implausible combinations were to mothers with diabetes; the remaining three had no documented medical explanation.Conclusions: In this study, use of the birth certificate CE rather than the LMP resulted in a clinically reliable reclassification for the majority of implausible birthweight‐for‐gestational age deliveries.
- Top Cited Papers
- 1 August 2015
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 49 (2) , 286-293
Nicotine and the Developing Human
- 1 August 2015
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 49 (2) , 286-293
Top Cited PapersNicotine and the Developing Human